Yishen Shujin Decoction for Fibromyalgia Syndrome
Recruiting
N/A
Interventional Study
Fibromyalgia Syndrome
At a Glance
- Age
- 18 – 75
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 100 (estimated)
- Sponsor
- Juan Jiao · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This 24-week prospective study (12-week intervention + 12-week follow-up) is a randomized, double-blind, placebo-controlled clinical trial designed to evaluate the therapeutic effects of YishenShujin Decoction, a clinically established herbal prescription, in patients with fibromyalgia (FM). The primary outcome is pain intensity measured by the Brief Pain Inventory (BPI). Secondary outcomes includ…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients with primary fibromyalgia who met the FM classification criteria established by the American College of Rheumatology in 2016.
* TCM syndromes of liver qi stagnation and yin blood insufficiency, or hepatic and renal yin deficiency.
* aged 18 years old and above, 75 yea…
Contacts